Albumin Articles
R-PR's DNA Patent Position Focused, But Vulnerable?
20 August 1998
Bayer Files For 2nd Generation Kogenate
25 June 1998
Chinese Product News
19 March 1998
UK To Import Blood Plasma
2 March 1998
Chiron's Rabies Vaccine OKed In USA
6 November 1997
Arterial Risk Dial Launched At IDF
24 July 1997
Positive Ph II Data With Alteon's Pimagedine
24 April 1997
WHO Calls For Ban On Human Cloning
19 March 1997
PPL Clones First Mammal From Adult Cells
3 March 1997
Celltech's CDP571 Shows Promise In Crohn's
3 March 1997
NEW YORK STOCK COMMENT
10 February 1997
No Major Changes To Be Made At Rhone-Poulenc
10 February 1997
Strong Year-End Results From R-P Rorer
3 February 1997
Roche Launches New Roferon A In UK
27 January 1997
Panel Recommends BeneFix For Approval
23 December 1996
Progress Revealed At Enzon
9 December 1996
R-PR's 18% EPS Rise Drives Parent Co In 3rd Qtr
4 November 1996
Centeon Albumin Recall Hits R-PR
21 October 1996
EU Approves Baxter's Takeover Of Immuno
21 October 1996
Rhone-Poulenc Rorer Beats 1st-Qtr Forecasts
6 May 1996
Rhone-Poulenc Rorer's "Year Of Firsts"
5 February 1996
Good Growth For Protein Drug Sector
23 October 1995
Developments In Iranian Health Care Sector
4 September 1995
Serun Tech produces transgenic goat
12 June 1995
EU Approval For Behringwerke/Armour Plasma Deal
10 April 1995
Prospects In Genetic-Based Cancer Therapies
27 March 1995
IGIV: Is Self-Sufficiency Possible In The EU?
21 November 1994
CPMP ADOPTS GUIDELINES/ DRUG CHARACTERISTICS
13 June 1994
PHASE I DATA ON rHb1.1 PRESENTED
18 April 1994
R-POULENC/MERIEUX MERGER IS ON
14 March 1994
EURO CPMP MEETING IN FEBRUARY
7 March 1994
RHONE-POULENC BID FOR FRENCH DISTRIBUTOR
28 February 1994
DECLINE AT RHONE-POULENC AS EXPECTED
21 February 1994
WORLD HEMATOLOGY MARKET FORECASTS
24 January 1994
EUROPEAN STOCK COMMENT
20 December 1993
BAD NEW FOR MEDIMMUNE AS RESPIGAM STUMBLES
13 December 1993
R-P HALTS ALBUMIN PRODUCTION
6 December 1993
BIOTEST SAYS IT IS UNFAIRLY ACCUSED
22 November 1993
RHONE-POULENC: A TRANSFORMATION
16 August 1993
IMMUNO AG BUYS BLOOD CENTER
16 August 1993
CPMP REPORTS ON JUNE MEETING ACTIONS
12 July 1993
BLOOD SUBSTITUTE FEARS UNFOUNDED?
19 April 1993
RHONE-POULENC INTEREST IN BLOOD PRODUCT SECTOR
1 March 1993
RHONE-POULENC RORER NET INCOME UP 13.4%
2 November 1992
EC CPMP MEETING RELEASES SPC GUIDELINES
29 June 1992
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
